NLRP3 and Parkinson disease: MSC derived exosomes modified by mimic-miR-7 can inhibit α- syn aggregates and inhibits NLRP3 inflammasome activation in SNPC and striatum, thereby improving neuroinflammatory response in PD (Yu et al., 2020).